Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.

Owen O'Connor, John Wright, Craig H. Moskowitz, Jamie Muzzy, Barbara MacGregor-Cortelli, Paul Hamlin, David Straus, Elizabeth Trehu, David P. Schenkein, Andrew D. Zelenetz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.'. Together they form a unique fingerprint.

Medicine & Life Sciences